JAMA Oncology/X
Jun 16, 2026, 15:26
JAMA Oncology: Avelumab Plus Methotrexate in Gestational Trophoblastic Tumors
JAMA Oncology shared a post on X about a paper by Benoit You et al. published in JAMA Oncology:
“Avelumab combined with methotrexate resulted in >95% durable remission and preserved fertility in low-risk gestational trophoblastic tumors, with a manageable safety profile.”
Title: Avelumab Plus Methotrexate for Gestational Trophoblastic Tumors
Authors: Benoit You, Jean-Pierre Lotz, Pierre Descargues
Read more.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Aug 3, 2026, 14:19Asmaa Khaled: The Success of IVF is Not Determined By the Number of Eggs Retrieved Alone…
-
Aug 3, 2026, 14:03Clare Mansfield: Sometimes the Path to Parenthood Changes, but the Dream Doesn’t Have To
-
Aug 3, 2026, 13:45Undiga Emuekpere: Basic Fertility Health Awareness Could Change Outcomes
-
Aug 3, 2026, 13:31Priyadatt Patel: A Quiet Inefficiency in How We Approach Infertility Deserves More Attention
-
Aug 3, 2026, 13:21Purabi Gunjal: Most Women Start Thinking about Fertility Too Late…
-
Aug 3, 2026, 13:10Juhee Jain: Empowering Women with the Right Information to Make Informed Decisions
-
Aug 3, 2026, 12:57Ashley Evans: Sometimes, the Thing that Got Me Through Fertility Treatment Wasn’t Positivity…
-
Aug 3, 2026, 12:42Devyanshi Dixit: Why Do the Best Healthcare Professionals Never Stop Learning?
-
Aug 3, 2026, 12:30Bringing Together the Brightest Minds in Reproductive Medicine for 3 Days at MEFS 2026